Investigation of the expression of genes affecting cytomatrix active zone function in the amygdala in schizophrenia: Effects of antipsychotic drugs

Journal of Psychiatric Research

Volumn 43, Issue 3, 2009, Pages 282-290

  Weidenhofer, Judith ^a,b,c   Scott, Rodney J ^a,c,d   Tooney, Paul A ^a,b,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^c HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^d JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Antipsychotic drugs; Cytomatrix active zone; Gene expression; Human amygdala; Presynaptic function; Schizophrenia

Indexed keywords

CLOZAPINE; HALOPERIDOL;

AMYGDALOID NUCLEUS; ARTICLE; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; CYTOMATRIX ACTIVE ZONE; DRUG EFFECT; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PICCOLO GENE; PRIORITY JOURNAL; RIMS2 GENE; RIMS3 GENE; SCHIZOPHRENIA;

ADULT; AMYGDALA; ANTIPSYCHOTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GTP-BINDING PROTEINS; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROPEPTIDES; POSTMORTEM CHANGES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 57749189599     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2008.04.001     Document Type: Article

References (35)

1. Aleman A., and Kahn R.S. Strange feelings do amygdala abnormalities dysregulate the emotional brain in schizophrenia?. Progress in Neurobiology 77 (2005) 283-298
2. Aston C., Jiang L., and Sokolov B.P. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. Journal of Neuroscience Research 77 (2004) 858-866
3. Bai O., Wei Z., Lu W., Bowen R., Keegan D., and Li X.-M. Protective effects of atypical antipsychotic drugs on pc12 cells after serum withdrawal. Journal of Neuroscience Research 69 (2002) 278-283
4. Baldessarini R., and Tarazi F. Drugs and the treatment of psychotic disorders: psychosis and mania. In: Hardman J., Limbird L., and Gilman A. (Eds). The pharmacological basis of therapeutics (2001), McGraw Hill, New York 485-520
5. Betz A., Thakur P., Junge H.J., Ashery U., Rhee J.-S., Scheuss V., et al. Functional interaction of the active zone proteins munc13-1 and rim1 in synaptic vesicle priming. Neuron 30 (2001) 183-196
6. Butz S., Okamoto M., and Sudhof T.C. A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Cell 94 (1998) 773-782
7. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1 (1988) 179-186
8. Castillo P.E., Schoch S., Schmitz F., Sudhof T.C., and Malenka R.C. Rim1α is required for presynaptic long-term potentiation. Nature 415 (2002) 327-330
9. Dresbach T., Qualmann B., Kessels M.M., Garner C.C., and Gundelfinger E.D. Review: the presynaptic cytomatrix of brain synapses. Cellular and Molecular Life Sciences 58 (2001) 94-116
10. Fenster S.D., Chung W.J., Zhai R., Cases-Langhoff C., Voss B., Garner A.M., et al. Piccolo, a presynaptic zinc finger protein structurally related to bassoon. Neuron 25 (2000) 203-214
11. 2+ sensor in pancreatic β-cells. Involvement of cAMP-GEFII:RIM2:PICCOLO complex in cAMP-dependent exocytosis. Journal of Biological Chemistry 277 (2002) 50497-50502
12. Fukuda M. Distinct rab binding specificity of rim1, rim2, rabphilin, and noc2. Identification of a critical determinant of rab3a/rab27a recognition by rim2. Journal of Biological Chemistry 278 (2003) 15373-15380
13. Hakak Y., Walker J., Li C., Hung Wong W., Davis K., Buxbaum J., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 4746-4751
14. Hemby S.E., Ginsberg S.D., Brunk B., Arnold S.E., Trojanowski J.Q., and Eberwine J.H. Gene expression profile for schizophrenia. Discrete neuron transcription patterns in the entorhinal cortex. Archives of General Psychiatry 59 (2002) 631-640
15. 2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biological Psychiatry 50 (2001) 873-883
16. Katsel P., Davis K.L., Gorman J.M., and Haroutunian V. Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophrenia Research 77 (2005) 241-252
17. Kontkanen O., Lakso M., Wong G., and Castren E. A functional genomic study of the effects of antipsychotic agent chlorpromazine in pc12 cells. Clinical Chemistry and Laboratory Medicine 28 (2000) 911-915
18. Kontkanen O., Toronen P., Lakso M., Wong G., and Castren E. Antipsychotic drug treatment induces differential gene expression in the rat cortex. Journal of Neurochemistry 83 (2002) 1043-1053
19. Martin T. Prime movers of synaptic vesicle exocytosis. Neuron 34 (2002) 9-12
20. Middleton F., Mirnics K., Pierri J., Lewis D., and Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. Journal of Neuroscience 22 (2002) 2718-2729
21. Mirnics K., Levitt P., and Lewis D.A. Critical appraisal of DNA microarrays in psychiatric genomics. Biological Psychiatry 60 (2006) 163-176
22. Mirnics K., Middleton F., Marquez A., Lewis D., and Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28 (2000) 53-67
23. Ohtsuka T., Takao-Rikitsu E., Inoue E., Inoue M., Takeuchi M., Matsubara K., et al. Cast: a novel protein of the cytomatrix at the active zone of synapses that forms a ternary complex with rim1 and munc13-1. Journal of Cell Biology 158 (2003) 577-590
24. Schoch S., Castillo P.E., Jo T., Mukherjee K., Geppert M., Wang Y., et al. Rim1α forms a protein scaffold for regulating neurotransmitter release at the active zone. Nature 415 (2002) 321-326
25. Schoch S., and Gundelfinger E.D. Molecular organization of the presynaptic active zone. Cell and Tissue Research 326 (2006) 379-391
26. 2+-triggered neurotransmitter release. EMBO Journal 25 (2006) 5852-5863
27. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1 (1987) 133-152
28. Sun L., Bittner M.A., and Holz R.W. Rim, a component of the presynaptic active zone and modulator of exocytosis, binds 14-3-3 through its N-terminus. Journal of Biological Chemistry 278 (2003) 38301-38309
29. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362 (2003) 798-805
30. Tom Dieck S., Sanmartí-Vila L., Langnaese K., Richter K., Kindler S., Soyke A., et al. Bassoon, a novel zinc-finger CAG/glutamine-repeat protein selectively localized at the active zone of presynaptic nerve terminals. Journal of Cell Biology 142 (1998) 499-509
31. Vawter M.P., Crook J., Hyde T., Kleinmann J., Weinberger D.R., Becker K.G., et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophrenia Research 58 (2002) 11-20
32. Wang Y., Okamoto M., Schmitz F., and Hofmann K. Sdhof TC Rim is a putative Rab3 effector in regulating synaptic-vesicle fusion. Nature 388 (1997) 593-598
33. 2 domain proteins. Journal of Biological Chemistry 275 (2000) 20033-20044
34. Weidenhofer J., Bowden N.A., Scott R.J., and Tooney P.A. Altered gene expression in the amygdala in schizophrenia: up-regulation of genes located in the cytomatrix active zone. Molecular and Cellular Neurosciences 31 (2006) 243-250
35. Wong A.H.C., and Van Tol H.H.M. Schizophrenia: from phenomenology to neurobiology. Neuroscience and Behavioural Reviews 27 (2003) 269-306